Log in or Sign up for Free to view tailored content for your specialty!
Rheumatoid Arthritis News
VIDEO: Role of JAK inhibitors in RA treatment
In this video, John M. Davis, III, MD, clinical rheumatologist and professor of medicine at Mayo Clinic College of Medicine and Science, discusses the role of JAK inhibitors in rheumatoid arthritis treatment, and growing understanding of their effects.
VIDEO: Links between RA, depression
In this video, John M. Davis, III, MD, clinical rheumatologist and professor of medicine at Mayo Clinic College of Medicine and Science, discusses the links between depression and rheumatoid arthritis, a relationship that he says could work both ways.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Biggest challenges in RA treatment
In this video, John M. Davis, III, MD, clinical rheumatologist and professor of medicine at Mayo Clinic College of Medicine and Science, discussed some of the biggest challenges in treating rheumatoid arthritis, including issues with infections and other comorbidities.
VIDEO: ‘Tantalizing advances’ in gut microbiome research in RA space
In this video, John M. Davis, III, MD, clinical rheumatologist and professor of medicine at Mayo Clinic College of Medicine and Science, discusses some of the latest advancements in the study and treatment of rheumatoid arthritis, including increased understanding of how the gut microbiome impacts the disease.
Q&A: Early detection of rheumatoid arthritis is vital in young adults
Katherine Terracina, MD, assistant professor of rheumatology with McGovern Medical School at UTHealth Houston, spoke with Healio about rheumatoid arthritis in young adults and how early detection from a primary care physician is vital for the best possible treatments.
Digital health application using patient input improves rheumatoid arthritis outcomes
Patients with rheumatoid arthritis who use a digital health application to assess their patient-reported outcomes are more likely to report controlled disease activity, according to data published in JAMA Network Open.
Switching to monotherapy for rheumatoid arthritis more effective for patients in LDA
Patients with rheumatoid arthritis who have lower disease activity are more likely to remain in remission after switching from combination therapy to monotherapy, according to data published in The Journal of Rheumatology.
Ozoralizumab exhibits long half-life, favorable pharmokinetics in rheumatoid arthritis
Ozoralizumab demonstrates a long half-life and favorable pharmacokinetics, as well as sustained efficacy, over 52 weeks in patients with rheumatoid arthritis, according to data published in Arthritis Research & Therapy.
Biologic DMARDs control ICI-associated inflammatory arthritis quicker than methotrexate
Patients with immune checkpoint inhibitor-associated inflammatory arthritis who receive a biologic DMARD demonstrate quicker arthritis control, but also experience faster cancer progression, vs. methotrexate, according to data.
Rheumatology patients with anxiety, depression demonstrate low self-management
Patients with anxiety or depression are less likely to exhibit healthy self-management for their rheumatoid arthritis, psoriatic arthritis or axial spondyloarthritis, according to data presented at EULAR 2023 Congress.
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read